MedTrace Logo

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

NCT01200875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2018-08-06

Study results available
· View outcomes & findings →

Summary

Platelet-Rich Plasma (PRP) has been banned in competitive athletes because some people think it may enhance athletic performance. However, there is very little published research to support or undermine this point of view. The purposes of this study are: (1) To assess the effects of local platelet-rich plasma (PRP) therapy on systemic levels of growth factors with suspected or known performance-enhancing effects; and (2) To understand whether the effect of PRP therapy on these growth factors differs between intramuscular and intratendinous PRP injections.

This research study is looking for 40 people who are receiving platelet-rich plasma therapy for a tendon or muscle injury. The study involves collecting seven blood samples (2 teaspoons each) from each patient, before and after the PRP treatment. Blood samples may be donated at any location of the patient's choosing, and participants will be paid for their time.

Conditions

  • Tendinopathy
  • Rheumatic Diseases

Interventions

PROCEDURE

Ultrasound-guided platelet-rich-plasma (PRP) injection

One ultrasound-guided intratendinous or intramuscular PRP injection

PROCEDURE

Platelet-Rich Plasma (PRP)

One ultrasound-guided PRP injection

Sponsors & Collaborators

Principal Investigators

  • Dr. Christina Herrero · New York University Langone Orthopedic Hospital

  • Dr. Jason L. Dragoo · Stanford University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200875 on ClinicalTrials.gov